Setuza, a Czech Republic pharmaceutical, chemicals and food producer, announced sales of 3.02 billion koruna ($114.8 million) for the first nine months of 1995, and pretax profits of 179 million koruna.
Although these results are better than in the corresponding period of 1994, the CTK news agency's Business News reports, they fall below the levels that the company had planned, mainly due to lower chemical and edible oil production. Setuza has said it expects sales for the year as a whole to reach 4.12 billion koruna, 18 million koruna up on the previous year, and pretax profits are forecast at 232 million koruna for this year.
...And Farmakon's New Ownership Announced A tender for the purchase of the Farmakon pharmaceutical producer in the north Moravia region of the Czech Republic has been won by Farmak, a company founded by Farmakon's employees, about half the 600 of whom hold shares in Farmak, reports Business News.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze